| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 294,802 | 404,001 | 204,035 | 161,283 | | Cost of Revenue | 202,664 | 317,593 | 139,966 | 110,803 | | | Gross Profit | 92,138 | 86,408 | 64,069 | 50,480 | | | Operating Expenses | | Research Development | 6,458 | 5,937 | 7,172 | 12,759 | | Selling General and Administrative | 45,306 | 44,117 | 32,960 | 39,165 | | Non Recurring | 1,197 | (123) | (3,075) | 55,342 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,377 | 36,477 | 27,012 | (56,786) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,319 | 4,192 | 1,347 | 4,839 | | Earnings Before Interest And Taxes | 44,496 | 40,669 | 28,359 | (51,947) | | Interest Expense | 1,773 | 2,595 | 2,567 | 1,258 | | Income Before Tax | 42,723 | 38,074 | 25,792 | (53,205) | | Income Tax Expense | 16,209 | 14,087 | 9,537 | (22,752) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,878 | 23,987 | 16,255 | (30,453) | | | Non-recurring Events | | Discontinued Operations | 352 | (176) | (176) | (1,498) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,866 | 23,811 | 16,079 | (31,951) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,866 | $23,811 | $16,079 | ($31,951) |
|
0.27% Nasdaq 
0.07%
Income Statement
